Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kraposhina (Krasnoyarsk, Russian Federation). Efficiency of specific prevention of pneumococcal infection at patients from risk groups  in Krasnoyarsk region. 4511

Member's Comments

No comment yet.

Related content which might interest you: The results of the TB control during of it epidemic in Ukraine on the base of the TB incidence in risk groups studying Source: Eur Respir J 2003; 22: Suppl. 45, 518s Year: 2003 Efficacy of vaccination to prevent pneumococcal infection in organized communities Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 The development of pneumococcal infection in military populations Source: Eur Respir J 2004; 24: Suppl. 48, 364s Year: 2004 Assessing the risk of tuberculosis infection in a vulnerable population group (ethnicity rrome) in a TB endemic population Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 Early childhood infections with rotavirus and norovirus are associated with risk of developing asthma Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy Year: 2011 The peculiarities of detecting TB in risk groups and identification of high-risk groups in TB control in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 196s Year: 2005 Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Role of pneumococcal vaccine on the incidence of childhood empyema Source: Breathe 2010; 6: 366-367 Year: 2010 Pneumococcal disease seasonality: incidence, severity and the role of influenza activity Source: Eur Respir J 2014; 43: 833-841 Year: 2014 Advancing global programmatic management of latent tuberculosis infection for at risk populations Source: Eur Respir J 2016; 47:1327-1330 Year: 2016 Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Aspects of the tuberculosis detection in children in an urban area with an increased morbidity of the disease Source: Eur Respir J 2003; 22: Suppl. 45, 518s Year: 2003 Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives Year: 2008 Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020 Effects of pneumococcal vaccine in patients with chronic respiratory disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Effects of pneumococcal vaccine in patients with chronic respiratory disease Source: Eur Respir Rev 2008; 17: 43-45 Year: 2008 Results of vaccination against pneumococcal infection in patients with chronic lung diseases Source: International Congress 2019 – Airway infection in COPD Year: 2019